Kingworld Sets 27 Aug 2026 Board Meeting to Approve 1H 2026 Results and Possible Dividend

Bulletin Express
Aug 14

Kingworld Medicines Group Limited (KINGWORLD) announced that its Board of Directors will convene on 27 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on an interim dividend proposal and other corporate matters.

The meeting is scheduled to be held in the Conference Room at Unit 613, 6th Floor, Goodluck Industrial Centre, 808 Lai Chi Kok Road, Kowloon, Hong Kong.

The notice, dated 14 August 2026, was signed by Chairman Zhao Li Sheng. Executive directors comprise Zhao Li Sheng, Chan Lok San and Zhou Xuhua, while independent non-executive directors are Duan Jidong, Wong Cheuk Lam and Dr. Chu Xiaoping.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10